Answers are grounded in this paper and cite their sources.
For enterococcal bacteremia, a daptomycin fAUC/MIC >27.43 was associated with 30-day survival among low-acuity patients. As pharmacodynamics for the approved dose are optimized only when MIC ≤1 mg/L, these data continue to stress the importance of reevaluation of the susceptibility breakpoint.
No takes yet. Share an insight, caveat, or question.
Avery et al. (2018) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: